{"id":"placebo-pill-for-varenicline","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo pills are inert formulations used as control comparators in clinical trials to establish the efficacy of active drugs like varenicline. They rely on psychological and psychophysiological mechanisms—patient expectation, conditioning, and natural disease course—rather than direct molecular action. In this context, the placebo serves as the comparator arm in varenicline smoking cessation trials conducted at UCLA.","oneSentence":"A placebo pill contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:21.856Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control comparator in varenicline smoking cessation clinical trials"}]},"trialDetails":[{"nctId":"NCT06582888","phase":"EARLY_PHASE1","title":"Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-11-19","conditions":"Nicotine Addiction, Craving","enrollment":200},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT05703672","phase":"PHASE3","title":"Switching to E-cigarettes in Smokers Not Interested in Quitting","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-07-17","conditions":"Smoking Reduction","enrollment":500},{"nctId":"NCT06679374","phase":"PHASE2","title":"Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease","status":"RECRUITING","sponsor":"Vikas Kotagal","startDate":"2025-04-09","conditions":"Parkinson Disease","enrollment":102},{"nctId":"NCT05541497","phase":"PHASE2","title":"Varenicline for Treatment of E-cigarette Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-11-04","conditions":"Smoking Cessation","enrollment":40},{"nctId":"NCT01511614","phase":"NA","title":"Nicotine Withdrawal Symptoms and Smoking Relapse","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2013-05-20","conditions":"Nicotine Dependence","enrollment":112},{"nctId":"NCT03980561","phase":"PHASE2","title":"UH3 Varenicline for Cannabis Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-01-31","conditions":"Cannabis Use Disorder","enrollment":174},{"nctId":"NCT01413516","phase":"PHASE2","title":"Varenicline In-Patient Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-08","conditions":"Smoking Cessation","enrollment":17},{"nctId":"NCT03176784","phase":"PHASE4","title":"UW Quitting Using Intensive Treatment Study (QUITS)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-11-11","conditions":"Tobacco Dependence","enrollment":1251},{"nctId":"NCT00554840","phase":"PHASE2","title":"Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2007-11","conditions":"Cigarette Smoking, Schizophrenia","enrollment":16},{"nctId":"NCT02859142","phase":"PHASE4","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-03-29","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":122},{"nctId":"NCT01027754","phase":"PHASE4","title":"Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2009-08","conditions":"Smoking Cessation, Substance-Related Disorders","enrollment":112},{"nctId":"NCT02797587","phase":"PHASE2, PHASE3","title":"Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2017-07-19","conditions":"HIV Infection, Alcohol Use, Smoking","enrollment":400},{"nctId":"NCT02351167","phase":"PHASE4","title":"Genetically Informed Smoking Cessation Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-05-20","conditions":"Smoking Cessation","enrollment":822},{"nctId":"NCT02360631","phase":"PHASE4","title":"Advancing Tobacco Use Treatment for African American Smokers","status":"COMPLETED","sponsor":"Lisa Sanderson Cox, PhD","startDate":"2015-07-29","conditions":"Smoking Cessation","enrollment":500},{"nctId":"NCT01756885","phase":"PHASE3","title":"Extended Varenicline Treatment for Smoking Among Cancer Patients","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2013-01","conditions":"Nicotine Dependence","enrollment":207},{"nctId":"NCT00794573","phase":"PHASE3","title":"Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial","status":"COMPLETED","sponsor":"Mark Eisenberg","startDate":"2009-09","conditions":"Acute Coronary Syndrome","enrollment":302},{"nctId":"NCT00756275","phase":"NA","title":"Varenicline and Motivational Advice for Smokers With Substance Use Disorders","status":"COMPLETED","sponsor":"Brown University","startDate":"2009-01","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":158},{"nctId":"NCT02488889","phase":"PHASE4","title":"Effects of Varenicline in Heavy Drinking Smokers","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2015-08","conditions":"Cigarette Smoking, Alcohol Consumption","enrollment":""},{"nctId":"NCT00713479","phase":"PHASE1","title":"An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2008-07","conditions":"Methamphetamine Addiction, Crystal Meth Addiction, Amphetamine Addiction","enrollment":8},{"nctId":"NCT01639560","phase":"PHASE4","title":"Varenicline for Light Smokers","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-01","conditions":"Smoking","enrollment":93},{"nctId":"NCT01347112","phase":"PHASE2, PHASE3","title":"Varenicline Treatment for Active Alcoholic Smokers","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-06","conditions":"Smoking, Tobacco Dependence, Alcohol Dependence","enrollment":33},{"nctId":"NCT01365819","phase":"PHASE2","title":"Varenicline for Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2012-02","conditions":"Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse","enrollment":52},{"nctId":"NCT00621777","phase":"PHASE4","title":"A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-02","conditions":"Schizophrenia, Schizoaffective Disorder, Bipolar Disorder","enrollment":247},{"nctId":"NCT01524627","phase":"PHASE2","title":"Effects of Varenicline on Smoking Reminders","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2011-12","conditions":"Nicotine Dependence","enrollment":124},{"nctId":"NCT01850953","phase":"PHASE4","title":"Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2013-06","conditions":"Craving, Smoking, Schizophrenia","enrollment":28},{"nctId":"NCT01772641","phase":"PHASE4","title":"A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2012-12","conditions":"Nicotine Addiction","enrollment":32},{"nctId":"NCT01314001","phase":"PHASE3","title":"Pharmacogenetics of Nicotine Addiction Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-12","conditions":"Nicotine Addiction","enrollment":1246},{"nctId":"NCT01532232","phase":"","title":"Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)","status":"TERMINATED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-02","conditions":"Breast Cancer, Tobacco Dependence","enrollment":7},{"nctId":"NCT00781755","phase":"PHASE4","title":"Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal","status":"WITHDRAWN","sponsor":"VA Boston Healthcare System","startDate":"","conditions":"Tobacco Use Disorder","enrollment":""},{"nctId":"NCT00948155","phase":"PHASE4","title":"Measuring Smoking Behaviors While Using Varenicline","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-01","conditions":"Nicotine Dependence","enrollment":48},{"nctId":"NCT00606892","phase":"NA","title":"Varenicline and Nicotine Interactions in Humans (VA)","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-08","conditions":"Smoking Cessation","enrollment":37},{"nctId":"NCT01146613","phase":"PHASE2","title":"Varenicline for Alcohol Dependence","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2011-02","conditions":"Alcoholism","enrollment":200},{"nctId":"NCT00918307","phase":"PHASE3","title":"Efficacy and Safety of Varenicline Among HIV-infected Patients","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2009-10","conditions":"HIV Infections, Tobacco Dependence","enrollment":248},{"nctId":"NCT01111149","phase":"PHASE2","title":"Varenicline and Smoking Cessation in Schizophrenia","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2009-12","conditions":"Schizophrenia, Smoking Cessation","enrollment":24},{"nctId":"NCT00935818","phase":"PHASE2, PHASE3","title":"Varenicline and Bupropion for Smoking Cessation","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-09","conditions":"Smoking","enrollment":506},{"nctId":"NCT01571167","phase":"PHASE1","title":"Varenicline as a Treatment for Methamphetamine Dependence","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2011-01","conditions":"Methamphetamine Dependence, Methamphetamine Abuse, Substance Abuse","enrollment":17},{"nctId":"NCT01011829","phase":"PHASE2","title":"Varenicline vs Placebo for the Treatment of Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2009-11","conditions":"Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse","enrollment":20},{"nctId":"NCT00733967","phase":"PHASE1","title":"Varenicline-Methamphetamine Interaction Study (2008)","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2008-01","conditions":"Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse","enrollment":""},{"nctId":"NCT00602927","phase":"NA","title":"Effects of Varenicline on Brain Activity During Nicotine Abstinence","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2007-11","conditions":"Nicotine Dependence","enrollment":38},{"nctId":"NCT00948649","phase":"PHASE4","title":"Effects of Chantix on Relapse Prevention for Smoking Cessation","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-09","conditions":"Nicotine Dependence","enrollment":62},{"nctId":"NCT00937508","phase":"PHASE4","title":"Smoking Cessation Program in the Preadmission Clinic","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2008-06","conditions":"Smoking","enrollment":290}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo pill (for varenicline)","genericName":"Placebo pill (for varenicline)","companyName":"University of California, Los Angeles","companyId":"university-of-california-los-angeles","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo pill contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control comparator in varenicline smoking cessation clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}